Clinical Trial: Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors

U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07504445) titled 'Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors' on Jan. 21, 2025.

Brief Summary: This is a prospective, open label, single arm clinical trial to evaluate the safety and the preliminary efficacy of chimeric antigen receptor-dendritic cell (CAR-DC) in the treatment of advanced solid tumors positive for one of the following antigens: ephrin type-A receptor 2 (EphA2), claudin-18 isoform 2 (CLDN18.2) , trophoblast cell surface antigen 2 (Trop2), human epidermal growth factor receptor 2 (HER2), guanylyl cyclase-C (GCC), glypican-3 (GPC3) and carcinoembryonic antigen (CEA).

Study Start Date: ...